Mid-term findings on echocardiography and computed tomography after RVOT-reconstruction: comparison of decellularized (SynerGraft) and conventional allografts

Objective: The immune response against human-leucocyte-antigens on donor-cells may be an important factor contributing to the degeneration of allograft-valves. We have previously reported that the use of the decellularized allograft SynerGraft(CryoLife®) reduces the immunologic response of the allog...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of cardio-thoracic surgery 2005-03, Vol.27 (3), p.410-415
Hauptverfasser: Bechtel, J.F. Matthias, Gellissen, Joerg, Erasmi, Armin W., Petersen, Michael, Hiob, Alexander, Stierle, Ulrich, Sievers, Hans-Hinrich
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 415
container_issue 3
container_start_page 410
container_title European journal of cardio-thoracic surgery
container_volume 27
creator Bechtel, J.F. Matthias
Gellissen, Joerg
Erasmi, Armin W.
Petersen, Michael
Hiob, Alexander
Stierle, Ulrich
Sievers, Hans-Hinrich
description Objective: The immune response against human-leucocyte-antigens on donor-cells may be an important factor contributing to the degeneration of allograft-valves. We have previously reported that the use of the decellularized allograft SynerGraft(CryoLife®) reduces the immunologic response of the allograft-recipient. In this study we compare the echocardiographic and computedtomography angiographic (CTA) findings of SynerGrafts with conventional cryopreserved allografts. Methods: 22 patients who received a pulmonary SynerGraft (SG-group) (21 during a Ross-procedure) underwent CTA and resting echocardiography (median: 10 months postoperatively). 47 randomly chosen patients who underwent a Ross-procedure served as controls (C-group) (median: 32 months postoperatively). Results: Neither the pressure gradients (mean: SG=9±4 vs C=10±4 mmHg; P=0.64) across the allograft, nor the effective orifice area (EOAI)(SG=0.93±0.80 vs C=0.93±0.42cm2/m2; P=0.96) differed between the groups. The EOAI showed a significant correlation with the smallest allograft-conduit-area measured on CTA (r=0.81; P
doi_str_mv 10.1016/j.ejcts.2004.12.017
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67480551</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1016/j.ejcts.2004.12.017</oup_id><sourcerecordid>67480551</sourcerecordid><originalsourceid>FETCH-LOGICAL-c460t-2a16375dfc4c55ee58bcea0178a3e85132bb7c0f4d47845496b1a7a052a494693</originalsourceid><addsrcrecordid>eNqNkcFu1DAURS0EomXgC5BQVggWCXbsxAk7VEGLWlqpFFTNxnLsl9ZDYgfbQQwfw7fW6YzKlpUt657jp3cReklwQTCp320K2KgYihJjVpCywIQ_Qoek4TTnlF0_TndMcM5bhg_QsxA2GOOalvwpOiAVZ7hlzSH6-8XoPIIfs95YbexNyJzNQN06Jb027sbL6XabSasz5cZpjqCz6MaH9z6x2eX3i6vcg3I2RD-raJx9fx-X3oSkc32mQcEwzEN6-ZMUb75uLfhjn_i3e7n9BXYh5ZDJYVg-6GN4jp70cgjwYn-u0LdPH6-OTvKzi-PPRx_OcsVqHPNSkprySveKqaoCqJpOgUwLaSSFpiK07DqucM804w2rWFt3RHKJq1KyltUtXaHXO-_k3c8ZQhSjCcvE0oKbg6g5a3CVRCtEd0HlXQgeejF5M0q_FQSLpRaxEfe1iKUWQUqRpkjUq71-7kbQ_5h9DylQ7AJunv7TmO8AEyL8fkCk_5FmTasQJ9drsT4_vyz56VpgegdvTqzG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67480551</pqid></control><display><type>article</type><title>Mid-term findings on echocardiography and computed tomography after RVOT-reconstruction: comparison of decellularized (SynerGraft) and conventional allografts</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Bechtel, J.F. Matthias ; Gellissen, Joerg ; Erasmi, Armin W. ; Petersen, Michael ; Hiob, Alexander ; Stierle, Ulrich ; Sievers, Hans-Hinrich</creator><creatorcontrib>Bechtel, J.F. Matthias ; Gellissen, Joerg ; Erasmi, Armin W. ; Petersen, Michael ; Hiob, Alexander ; Stierle, Ulrich ; Sievers, Hans-Hinrich</creatorcontrib><description>Objective: The immune response against human-leucocyte-antigens on donor-cells may be an important factor contributing to the degeneration of allograft-valves. We have previously reported that the use of the decellularized allograft SynerGraft(CryoLife®) reduces the immunologic response of the allograft-recipient. In this study we compare the echocardiographic and computedtomography angiographic (CTA) findings of SynerGrafts with conventional cryopreserved allografts. Methods: 22 patients who received a pulmonary SynerGraft (SG-group) (21 during a Ross-procedure) underwent CTA and resting echocardiography (median: 10 months postoperatively). 47 randomly chosen patients who underwent a Ross-procedure served as controls (C-group) (median: 32 months postoperatively). Results: Neither the pressure gradients (mean: SG=9±4 vs C=10±4 mmHg; P=0.64) across the allograft, nor the effective orifice area (EOAI)(SG=0.93±0.80 vs C=0.93±0.42cm2/m2; P=0.96) differed between the groups. The EOAI showed a significant correlation with the smallest allograft-conduit-area measured on CTA (r=0.81; P&lt;0.001) which was most frequently (n=34) found in the proximal postvalvular tubular part of the conduit. Calcifications (n=11) or a fibroproliferative reaction (n=15) were rarely observed. Overall, there were no radiologic differences between the groups. On CTA, the smallest diameter of the allograft-conduits was significantly smaller than the diameter given on the cryopreservation protocol (SG=16±3a nd C=17±3 mm vs 25 mm in both groups; P&lt;0.001 each) whereas the diameter of the distal part of the allograft was not(SG=24±2, P=0.066, and C=25±3 mm, P=0.82). Conclusions: Despite a significantshorter follow-up in the SynerGraft-group, no functional or radiologic differences were observed as compared to control-patients. The smallest diameter is located almost exclusively at the proximal level of allograft-conduits.</description><identifier>ISSN: 1010-7940</identifier><identifier>EISSN: 1873-734X</identifier><identifier>DOI: 10.1016/j.ejcts.2004.12.017</identifier><identifier>PMID: 15740948</identifier><language>eng</language><publisher>Germany: Elsevier Science B.V</publisher><subject>Adult ; Allograft ; Aortic Valve - surgery ; Bioprosthesis ; Calcification ; Computed tomography ; Cryopreservation ; Echocardiography ; Female ; Follow-Up Studies ; Graft Survival - immunology ; Heart Valve Diseases - surgery ; Heart Valve Prosthesis ; Heartvalve ; Humans ; Imaging ; Immunology ; Male ; Middle Aged ; Prosthesis Failure ; Pulmonary Valve - diagnostic imaging ; Pulmonary Valve - immunology ; Pulmonary Valve - transplantation ; Tomography, X-Ray Computed ; Transplantation, Heterologous - immunology ; Ultrasonography</subject><ispartof>European journal of cardio-thoracic surgery, 2005-03, Vol.27 (3), p.410-415</ispartof><rights>2005 Elsevier B.V. 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c460t-2a16375dfc4c55ee58bcea0178a3e85132bb7c0f4d47845496b1a7a052a494693</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15740948$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bechtel, J.F. Matthias</creatorcontrib><creatorcontrib>Gellissen, Joerg</creatorcontrib><creatorcontrib>Erasmi, Armin W.</creatorcontrib><creatorcontrib>Petersen, Michael</creatorcontrib><creatorcontrib>Hiob, Alexander</creatorcontrib><creatorcontrib>Stierle, Ulrich</creatorcontrib><creatorcontrib>Sievers, Hans-Hinrich</creatorcontrib><title>Mid-term findings on echocardiography and computed tomography after RVOT-reconstruction: comparison of decellularized (SynerGraft) and conventional allografts</title><title>European journal of cardio-thoracic surgery</title><addtitle>Eur J Cardiothorac Surg</addtitle><addtitle>Eur J Cardiothorac Surg</addtitle><description>Objective: The immune response against human-leucocyte-antigens on donor-cells may be an important factor contributing to the degeneration of allograft-valves. We have previously reported that the use of the decellularized allograft SynerGraft(CryoLife®) reduces the immunologic response of the allograft-recipient. In this study we compare the echocardiographic and computedtomography angiographic (CTA) findings of SynerGrafts with conventional cryopreserved allografts. Methods: 22 patients who received a pulmonary SynerGraft (SG-group) (21 during a Ross-procedure) underwent CTA and resting echocardiography (median: 10 months postoperatively). 47 randomly chosen patients who underwent a Ross-procedure served as controls (C-group) (median: 32 months postoperatively). Results: Neither the pressure gradients (mean: SG=9±4 vs C=10±4 mmHg; P=0.64) across the allograft, nor the effective orifice area (EOAI)(SG=0.93±0.80 vs C=0.93±0.42cm2/m2; P=0.96) differed between the groups. The EOAI showed a significant correlation with the smallest allograft-conduit-area measured on CTA (r=0.81; P&lt;0.001) which was most frequently (n=34) found in the proximal postvalvular tubular part of the conduit. Calcifications (n=11) or a fibroproliferative reaction (n=15) were rarely observed. Overall, there were no radiologic differences between the groups. On CTA, the smallest diameter of the allograft-conduits was significantly smaller than the diameter given on the cryopreservation protocol (SG=16±3a nd C=17±3 mm vs 25 mm in both groups; P&lt;0.001 each) whereas the diameter of the distal part of the allograft was not(SG=24±2, P=0.066, and C=25±3 mm, P=0.82). Conclusions: Despite a significantshorter follow-up in the SynerGraft-group, no functional or radiologic differences were observed as compared to control-patients. The smallest diameter is located almost exclusively at the proximal level of allograft-conduits.</description><subject>Adult</subject><subject>Allograft</subject><subject>Aortic Valve - surgery</subject><subject>Bioprosthesis</subject><subject>Calcification</subject><subject>Computed tomography</subject><subject>Cryopreservation</subject><subject>Echocardiography</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Graft Survival - immunology</subject><subject>Heart Valve Diseases - surgery</subject><subject>Heart Valve Prosthesis</subject><subject>Heartvalve</subject><subject>Humans</subject><subject>Imaging</subject><subject>Immunology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prosthesis Failure</subject><subject>Pulmonary Valve - diagnostic imaging</subject><subject>Pulmonary Valve - immunology</subject><subject>Pulmonary Valve - transplantation</subject><subject>Tomography, X-Ray Computed</subject><subject>Transplantation, Heterologous - immunology</subject><subject>Ultrasonography</subject><issn>1010-7940</issn><issn>1873-734X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkcFu1DAURS0EomXgC5BQVggWCXbsxAk7VEGLWlqpFFTNxnLsl9ZDYgfbQQwfw7fW6YzKlpUt657jp3cReklwQTCp320K2KgYihJjVpCywIQ_Qoek4TTnlF0_TndMcM5bhg_QsxA2GOOalvwpOiAVZ7hlzSH6-8XoPIIfs95YbexNyJzNQN06Jb027sbL6XabSasz5cZpjqCz6MaH9z6x2eX3i6vcg3I2RD-raJx9fx-X3oSkc32mQcEwzEN6-ZMUb75uLfhjn_i3e7n9BXYh5ZDJYVg-6GN4jp70cgjwYn-u0LdPH6-OTvKzi-PPRx_OcsVqHPNSkprySveKqaoCqJpOgUwLaSSFpiK07DqucM804w2rWFt3RHKJq1KyltUtXaHXO-_k3c8ZQhSjCcvE0oKbg6g5a3CVRCtEd0HlXQgeejF5M0q_FQSLpRaxEfe1iKUWQUqRpkjUq71-7kbQ_5h9DylQ7AJunv7TmO8AEyL8fkCk_5FmTasQJ9drsT4_vyz56VpgegdvTqzG</recordid><startdate>200503</startdate><enddate>200503</enddate><creator>Bechtel, J.F. Matthias</creator><creator>Gellissen, Joerg</creator><creator>Erasmi, Armin W.</creator><creator>Petersen, Michael</creator><creator>Hiob, Alexander</creator><creator>Stierle, Ulrich</creator><creator>Sievers, Hans-Hinrich</creator><general>Elsevier Science B.V</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200503</creationdate><title>Mid-term findings on echocardiography and computed tomography after RVOT-reconstruction: comparison of decellularized (SynerGraft) and conventional allografts</title><author>Bechtel, J.F. Matthias ; Gellissen, Joerg ; Erasmi, Armin W. ; Petersen, Michael ; Hiob, Alexander ; Stierle, Ulrich ; Sievers, Hans-Hinrich</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c460t-2a16375dfc4c55ee58bcea0178a3e85132bb7c0f4d47845496b1a7a052a494693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Allograft</topic><topic>Aortic Valve - surgery</topic><topic>Bioprosthesis</topic><topic>Calcification</topic><topic>Computed tomography</topic><topic>Cryopreservation</topic><topic>Echocardiography</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Graft Survival - immunology</topic><topic>Heart Valve Diseases - surgery</topic><topic>Heart Valve Prosthesis</topic><topic>Heartvalve</topic><topic>Humans</topic><topic>Imaging</topic><topic>Immunology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prosthesis Failure</topic><topic>Pulmonary Valve - diagnostic imaging</topic><topic>Pulmonary Valve - immunology</topic><topic>Pulmonary Valve - transplantation</topic><topic>Tomography, X-Ray Computed</topic><topic>Transplantation, Heterologous - immunology</topic><topic>Ultrasonography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bechtel, J.F. Matthias</creatorcontrib><creatorcontrib>Gellissen, Joerg</creatorcontrib><creatorcontrib>Erasmi, Armin W.</creatorcontrib><creatorcontrib>Petersen, Michael</creatorcontrib><creatorcontrib>Hiob, Alexander</creatorcontrib><creatorcontrib>Stierle, Ulrich</creatorcontrib><creatorcontrib>Sievers, Hans-Hinrich</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cardio-thoracic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bechtel, J.F. Matthias</au><au>Gellissen, Joerg</au><au>Erasmi, Armin W.</au><au>Petersen, Michael</au><au>Hiob, Alexander</au><au>Stierle, Ulrich</au><au>Sievers, Hans-Hinrich</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mid-term findings on echocardiography and computed tomography after RVOT-reconstruction: comparison of decellularized (SynerGraft) and conventional allografts</atitle><jtitle>European journal of cardio-thoracic surgery</jtitle><stitle>Eur J Cardiothorac Surg</stitle><addtitle>Eur J Cardiothorac Surg</addtitle><date>2005-03</date><risdate>2005</risdate><volume>27</volume><issue>3</issue><spage>410</spage><epage>415</epage><pages>410-415</pages><issn>1010-7940</issn><eissn>1873-734X</eissn><abstract>Objective: The immune response against human-leucocyte-antigens on donor-cells may be an important factor contributing to the degeneration of allograft-valves. We have previously reported that the use of the decellularized allograft SynerGraft(CryoLife®) reduces the immunologic response of the allograft-recipient. In this study we compare the echocardiographic and computedtomography angiographic (CTA) findings of SynerGrafts with conventional cryopreserved allografts. Methods: 22 patients who received a pulmonary SynerGraft (SG-group) (21 during a Ross-procedure) underwent CTA and resting echocardiography (median: 10 months postoperatively). 47 randomly chosen patients who underwent a Ross-procedure served as controls (C-group) (median: 32 months postoperatively). Results: Neither the pressure gradients (mean: SG=9±4 vs C=10±4 mmHg; P=0.64) across the allograft, nor the effective orifice area (EOAI)(SG=0.93±0.80 vs C=0.93±0.42cm2/m2; P=0.96) differed between the groups. The EOAI showed a significant correlation with the smallest allograft-conduit-area measured on CTA (r=0.81; P&lt;0.001) which was most frequently (n=34) found in the proximal postvalvular tubular part of the conduit. Calcifications (n=11) or a fibroproliferative reaction (n=15) were rarely observed. Overall, there were no radiologic differences between the groups. On CTA, the smallest diameter of the allograft-conduits was significantly smaller than the diameter given on the cryopreservation protocol (SG=16±3a nd C=17±3 mm vs 25 mm in both groups; P&lt;0.001 each) whereas the diameter of the distal part of the allograft was not(SG=24±2, P=0.066, and C=25±3 mm, P=0.82). Conclusions: Despite a significantshorter follow-up in the SynerGraft-group, no functional or radiologic differences were observed as compared to control-patients. The smallest diameter is located almost exclusively at the proximal level of allograft-conduits.</abstract><cop>Germany</cop><pub>Elsevier Science B.V</pub><pmid>15740948</pmid><doi>10.1016/j.ejcts.2004.12.017</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1010-7940
ispartof European journal of cardio-thoracic surgery, 2005-03, Vol.27 (3), p.410-415
issn 1010-7940
1873-734X
language eng
recordid cdi_proquest_miscellaneous_67480551
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Adult
Allograft
Aortic Valve - surgery
Bioprosthesis
Calcification
Computed tomography
Cryopreservation
Echocardiography
Female
Follow-Up Studies
Graft Survival - immunology
Heart Valve Diseases - surgery
Heart Valve Prosthesis
Heartvalve
Humans
Imaging
Immunology
Male
Middle Aged
Prosthesis Failure
Pulmonary Valve - diagnostic imaging
Pulmonary Valve - immunology
Pulmonary Valve - transplantation
Tomography, X-Ray Computed
Transplantation, Heterologous - immunology
Ultrasonography
title Mid-term findings on echocardiography and computed tomography after RVOT-reconstruction: comparison of decellularized (SynerGraft) and conventional allografts
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T04%3A39%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mid-term%20findings%20on%20echocardiography%20and%20computed%20tomography%20after%20RVOT-reconstruction:%20comparison%20of%20decellularized%20(SynerGraft)%20and%20conventional%20allografts&rft.jtitle=European%20journal%20of%20cardio-thoracic%20surgery&rft.au=Bechtel,%20J.F.%20Matthias&rft.date=2005-03&rft.volume=27&rft.issue=3&rft.spage=410&rft.epage=415&rft.pages=410-415&rft.issn=1010-7940&rft.eissn=1873-734X&rft_id=info:doi/10.1016/j.ejcts.2004.12.017&rft_dat=%3Cproquest_cross%3E67480551%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67480551&rft_id=info:pmid/15740948&rft_oup_id=10.1016/j.ejcts.2004.12.017&rfr_iscdi=true